FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium

BACKGROUND: Large pragmatic studies of patients who received 5-fluorouracil with leucovorin, irinotecan, and oxaliplatin ([m]FOLFIRINOX) as initial treatment for localized pancreatic ductal adenocarcinoma (PDAC) are lacking. This study aimed to provide realistic estimates of oncologic outcomes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Quisette P, van Dam, Jacob L, Doppenberg, Deesje, Prakash, Laura R, van Eijck, Casper H J, Jarnagin, William R, O’ Reilly, Eileen M, Paniccia, Alessandro, Besselink, Marc G, Katz, Matthew H G, Tzeng, Ching-Wei D, Wei, Alice C, Zureikat, Amer H, Groot Koerkamp, Bas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086789/
https://www.ncbi.nlm.nih.gov/pubmed/35157075
http://dx.doi.org/10.1093/jnci/djac018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086789/
https://www.ncbi.nlm.nih.gov/pubmed/35157075
http://dx.doi.org/10.1093/jnci/djac018

Ejemplares similares